Advertisement
ESTA vs NVST
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESTA is a Buy and NVST is a Buy.
ESTA in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 13, 2026
ESTA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 31 cases where ESTA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ESTA's RSI Oscillator exited the oversold zone, 23 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on ESTA as a result. In 82 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
The Moving Average Convergence Divergence (MACD) for ESTA just turned positive on October 20, 2026. Looking at past instances where ESTA's MACD turned positive, the stock continued to rise in 45 of 53 cases over the following month. The odds of a continued upward trend are 85%.
Following a +4.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where ESTA advanced for three days, in 240 of 308 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 50-day moving average for ESTA moved below the 200-day moving average on October 08, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ESTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for ESTA entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ESTA's P/B Ratio (87.611) is very high in comparison to the industry average of (2.874). P/E Ratio (-50.016) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (8.749) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. ESTA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ESTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
NVST's RSI Oscillator recovers from oversold territory
The RSI Oscillator for NVST moved out of oversold territory on October 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In 19 of the 27 cases the stock moved higher. This puts the odds of a move higher at 70%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on NVST as a result. In 69 of 107 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
The Moving Average Convergence Divergence (MACD) for NVST just turned positive on October 06, 2026. Looking at past instances where NVST's MACD turned positive, the stock continued to rise in 34 of 51 cases over the following month. The odds of a continued upward trend are 67%.
Following a +4.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where NVST advanced for three days, in 176 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
NVST broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for NVST entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. NVST’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.252) is normal, around the industry mean (4.961). P/E Ratio (40.627) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.451) is also within normal values, averaging (56.876).
The Tickeron PE Growth Rating for this company is 82 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
ESTA | NVST | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 85 | 81 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 13 Undervalued | 63 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 87 | |
PRICE GROWTH RATING 1..100 | 62 | 58 | |
P/E GROWTH RATING 1..100 | 15 | 82 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ESTA's Valuation (13) in the Medical Specialties industry is somewhat better than the same rating for NVST (63) in the null industry. This means that ESTA’s stock grew somewhat faster than NVST’s over the last 12 months.
ESTA's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NVST (100) in the null industry. This means that ESTA’s stock grew similarly to NVST’s over the last 12 months.
NVST's SMR Rating (87) in the null industry is in the same range as ESTA (99) in the Medical Specialties industry. This means that NVST’s stock grew similarly to ESTA’s over the last 12 months.
NVST's Price Growth Rating (58) in the null industry is in the same range as ESTA (62) in the Medical Specialties industry. This means that NVST’s stock grew similarly to ESTA’s over the last 12 months.
ESTA's P/E Growth Rating (15) in the Medical Specialties industry is significantly better than the same rating for NVST (82) in the null industry. This means that ESTA’s stock grew significantly faster than NVST’s over the last 12 months.
| ESTA | NVST | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 79% | 1 day ago 70% |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 79% |
| Momentum ODDS (%) | 1 day ago 85% | 1 day ago 64% |
| MACD ODDS (%) | 1 day ago 85% | 1 day ago 67% |
| TrendWeek ODDS (%) | 1 day ago 81% | 1 day ago 67% |
| TrendMonth ODDS (%) | 1 day ago 79% | 1 day ago 72% |
| Advances ODDS (%) | 1 day ago 78% | 1 day ago 64% |
| Declines ODDS (%) | 4 days ago 77% | 4 days ago 70% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 76% |
| Aroon ODDS (%) | 1 day ago 75% | 1 day ago 79% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ESTA’s FA Score shows that 2 FA rating(s) are green while NVST’s FA Score has 0 green FA rating(s).
- ESTA’s FA Score: 2 green, 3 red.
- NVST’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ESTA’s TA Score shows that 5 TA indicator(s) are bullish while NVST’s TA Score has 4 bullish TA indicator(s).
- ESTA’s TA Score: 5 bullish, 4 bearish.
- NVST’s TA Score: 4 bullish, 4 bearish.
Price Growth
ESTA (@Medical/Nursing Services) experienced а +3.52% price change this week, while NVST (@Pharmaceuticals: Other) price change was +2.00% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.50%. For the same industry, the average monthly price growth was -10.64%, and the average quarterly price growth was -10.25%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.59%. For the same industry, the average monthly price growth was -3.91%, and the average quarterly price growth was +7.47%.
Reported Earning Dates
ESTA is expected to report earnings on Oct 29, 2026.
NVST is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Medical/Nursing Services (-1.50% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (+0.59% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
ESTA and
Correlation & Price change
A.I.dvisor indicates that over the last year, ESTA has been loosely correlated with NPCE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ESTA jumps, then NPCE could also see price increases.
| Ticker / NAME | Correlation To ESTA | 1D Price Change % | ||
|---|---|---|---|---|
| ESTA | 100% | +1.99% | ||
| NPCE - ESTA | 46% Loosely correlated | +0.69% | ||
| RDNT - ESTA | 41% Loosely correlated | +2.70% | ||
| NVST - ESTA | 39% Loosely correlated | +3.36% | ||
| NTRA - ESTA | 37% Loosely correlated | -2.91% | ||
| ISRG - ESTA | 36% Loosely correlated | +3.67% | ||
More | ||||
NVST and
Correlation & Price change
A.I.dvisor indicates that over the last year, NVST has been closely correlated with ALGN. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVST jumps, then ALGN could also see price increases.
| Ticker / NAME | Correlation To NVST | 1D Price Change % | ||
|---|---|---|---|---|
| NVST | 100% | +3.36% | ||
| ALGN - NVST | 70% Closely correlated | +2.74% | ||
| XRAY - NVST | 60% Loosely correlated | +4.63% | ||
| BIO - NVST | 57% Loosely correlated | +0.83% | ||
| A - NVST | 55% Loosely correlated | -2.17% | ||
| MTD - NVST | 52% Loosely correlated | +0.40% | ||
More | ||||